FDA Finds Violations to Seafood Facilities in Peru, Japan
The Food and Drug Administration recently sent warning letters to seafood processors in Japan and Peru threatening detention of their fish products at the border unless violations of seafood hazard analysis and critical control point (HACCP) regulations are corrected. In…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
a letter sent to Inversiones Peru Pacifico dated July 14, FDA cited problems with the company’s mahi mahi products processed at its Sullana, Peru facility (here). In another warning letter dated July 7, FDA told Marutoshi that bonita tuna flake products from its Kagoshima facility are adulterated because of HACCP violations (here). The agency threatened to place both on import alert and detain affected fish products without further examination. It also said it would collect reinspection fees from the companies’ U.S. agents for any reinspection conducted to verify compliance.